Epstein-Barr virus infection in the neoplastic and nonneoplastic cells of lymphoid malignancies

Cancer

Volumn 77, Issue 11, 1996, Pages 2339-2347

  Teramoto, Norihiro ^a   Sarker, Ashit Baran ^a   Tonoyama, Yuji ^a   Yoshino, Tadashi ^a   Hayashi, Kazuhiko ^a   Takahashi, Kiyoshi ^a   Akagi, Tadaatsu ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

EBER 1; EBNA2; Hodgkin's disease; in situ hybridization; LMP 1; non Hodgkin's malignant lymphoma; Southern hybridization; ZEBRA

Indexed keywords

CD20 ANTIGEN; CD45 ANTIGEN; MEMBRANE ANTIGEN; MONOCLONAL ANTIBODY; VIRUS ANTIGEN; VIRUS DNA;

ARTICLE; B CELL LYMPHOMA; CELL LABELING; CONTROLLED STUDY; EPSTEIN BARR VIRUS; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; NATURAL KILLER CELL; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SOUTHERN BLOTTING; T CELL LYMPHOMA; VIRUS INFECTION;

ANTIGENS, VIRAL; BASE SEQUENCE; CELL LINEAGE; DNA, VIRAL; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HODGKIN DISEASE; HUMANS; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LYMPHOCYTES; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL; MOLECULAR SEQUENCE DATA; REED-STERNBERG CELLS; RETROSPECTIVE STUDIES; RNA, VIRAL; TUMOR STEM CELLS; TUMOR VIRUS INFECTIONS; VIRAL PROTEINS; VIRUS LATENCY;

EID: 0029897143     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960601)77:11<2339::AID-CNCR24>3.0.CO;2-X     Document Type: Article

References (30)

1. Klein G. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 1989;58:5-8.
2. Klein G. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 1994;77:791-93.
3. Miller G. Epstein-Barr Virus. Biology, pathogenesis, and medical aspects. In: Fields BN, Knipe DM, editors. Virology. 2nd edition. New York: Raven Press, 1990:1921-58.
4. Ambinder RF, Mann RB. Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994;145:239-52.
5. Rowe M, Lear AL, Groom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 1992;66:122-31.
6. Henle W, Henle G. Epstein-Barr virus and infectious mononucleosis. N Engl J Med 1973;288:263-4.
7. Niedobitek G, Young LS, Sam CK, Brooks L, Prasad U, Rickinson AB. Expression of Epstein-Barr virus genes and of lymphocyte activation molecules in undifferentiated nasopharyngeal carcinomas. Am J Pathol 1992;140:879-87.
8. Fukayama M, Ibuka T, Hayashi Y, Ooba T, Koike M, Mizutani S. Epstein-Barr virus in pyothorax-associated pleural lymphoma. Am J Pathol 1993;143:1044-9.
9. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, Karkov J, Black F, Skinhoj P, et al. AIDS-related lymphoma. Histopathology, immunophenotype, and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991;138:149-63.
10. Hardarson S, Anderson ME, Lutz CT. Presence of Epstein-Barr virus in many types of benign and malignant lymphoid lesions: detection by polymerase chain reaction and in situ hybridization. Diagn Mol Pathol 1994;3:22-31.
11. Chang KL, Chen YY, Shibata D, Weiss LM. Description of an in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992; 1:246-55.
12. Pallesen G, Hamilton-Dutoit SJ, Rowe M, Lisse I, Ralfkiaer E, Sandvej K, et al. Expression of Epstein-Barr virus replicative proteins in AIDS-related non-Hodgkin's lymphoma cells. J Pathol 1991;165:289-99.
13. Weiss LM, Chen YY, Liu XF, Shibata D. Epstein-Barr virus and Hodgkin's disease. Am J Pathol 1991;139:1259-65.
14. Teramoto N, Akagi T, Yoshino T, Takahashi K, Jeon HJ. Direct detection of Epstein-Barr virus DNA from a single Reed-Sternberg cell of Hodgkin's disease by polymerase chain reaction. Jpn J Cancer Res 1992;83:329-33.
15. Thomas JA, Hotchin NA, Allday MJ, Amlot P, Rose M, Yacoub M, et al. Immunohistology of Epstein-Barr virus-associated antigens in B-cell disorders from immunocompromised individuals. Transplantation 1990;49:944-53.
16. Harabuchi Y, Yamanaka K, Kataura A, Imai S, Kinoshita T, Mizuno F, et al. Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granuloma. Lancet 1990;335:128-30.
17. Oda K, Tamaru J, Takenouchi T, Mikata A, Nunomura M, Saitoh N, et al. Association of Epstein-Barr virus with gastric carcinoma with lymphoid stroma. Am J Pathol 1993; 143: 1063-71.
18. Raab-Traub N, Rajadurai P, Flynn K, Lanier AP. Epstein-Barr virus infection in carcinoma of the salivary gland. J Virol 1991;65:7032-6.
19. 1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J 1994;13:3321-8.
20. Miller G. The switch between latency and replication of Epstein-Barr virus. J Infect Dis 1990;161:833-44.
21. Pallesen G, Sandvej K, Hamilton-Dutoit SJ, Rowe M, Young LS. Activation of Epstein-Barr virus replication in Hodgkin and Reed-Sternberg cells. Blood 1991;78:1162-5.
22. Young LS, Lau R, Rowe M, Niedobitek G, Packham G, Shanahan F, et al. Differentiation-associated expression of the Epstein-Barr virus BZLF1 transactivator protein in oral hairy leukoplakia. J Virol 1991;65:2868-74.
23. Brousset P, Knecht H, Rubin B, Drouet E, Chittal S, Meggetto F, et al. Demonstration of Epstein-Barr virus replication in Reed-Sternberg cells of Hodgkin's disease. Blood 1993; 82:872-6.
24. The Non-Hodgkin's lymphoma pathologic classification project. National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas. Summary and description of a working formulation for clinical usage. Cancer 1982;49:2112-35.
25. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
26. Anagnostopoulos I, Herbst H, Niedobitek G, Stein H. Demonstration of monoclonal EBV genomes in Hodgkin's disease and KI-1-positive anaplastic large cell lymphoma by combined Southern blot and in situ hybridization. Blood 1989;74:810-6,
27. Krishnan J, Wallberg K, Frizzera G. T-cell-rich large B-cell lymphoma. A study of 30 cases, supporting its histologic heterogeneity and lack of clinical distinctiveness. Am J Surg Pathol 1994;18:455-65.
28. Hsu SM, Waldron JW, Hsu PL, Hough AJ. Cytokines in malignant lymphomas: review and prospective evaluation. Hum Pathol 1993;24:1040-57.
29. Burdin N, Peronne C, Banchereau J, Roussel F. Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10. J Exp Med 1993;177:295-304.
30. Miyazaki I, Cheung RK, Dosch HM. Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus. J Exp Med 1993;178:439-47.